The global market for Biopreservation is estimated at US$4.6 Billion in 2023 and is projected to reach US$7.9 Billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.
Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Biopreservation Media segment, which is expected to reach US$5.1 Billion by 2030 with a CAGR of a 8.7%. The Biopreservation Equipment segment is also set to grow at 6.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.2 Billion in 2023, and China, forecasted to grow at an impressive 11.9% CAGR to reach $2.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biopreservation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biopreservation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biopreservation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Atlanta Biologicals, Inc., BioCision, LLC, BioGenix, LLC, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 27 Featured):
- Atlanta Biologicals, Inc.
- BioCision, LLC
- BioGenix, LLC
- BioLife Solutions, Inc.
- Biomatrica, Inc.
- LabVantage Solutions, Inc.
- Panasonic Corporation
- Qiagen, Inc.
- Thermo Fisher Scientific, Inc.
- VWR International LLC
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Atlanta Biologicals, Inc.
- BioCision, LLC
- BioGenix, LLC
- BioLife Solutions, Inc.
- Biomatrica, Inc.
- LabVantage Solutions, Inc.
- Panasonic Corporation
- Qiagen, Inc.
- Thermo Fisher Scientific, Inc.
- VWR International LLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 178 |
Published | December 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 4.6 Billion |
Forecasted Market Value ( USD | $ 7.9 Billion |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |